论文部分内容阅读
目的:观察分析米非司酮治疗绝经过渡期功能性子宫出血的临床效果。方法:选择我院曾接收的绝经过渡期功能性子宫出血患者108例,将这些患者随机分为两组,其中对照组用炔诺酮治疗,观察组用米非司酮治疗,对两组患者的临床治疗效果进行观察。结果:观察组临床总有效率为96.3%,对照组临床总有效率为74.1%,两组患者之间差异具有统计学意义。观察组不良反应发生率为3.7%、对照组不良反应发生率18.5%。结论:米非司酮对绝经过渡期患者所出现的功能性子宫出血临床治疗效果良好,不良反应少,可在临床推广应用。
Objective: To observe and analyze the clinical effect of mifepristone in the treatment of functional uterine bleeding in menopause transitional period. Methods: One hundred and eighty patients with functional uterine bleeding who had received menopause in our hospital were selected. These patients were randomly divided into two groups. The control group was treated with norethindrone, and the observation group was treated with mifepristone. The clinical treatment effect was observed. Results: The total clinical effective rate was 96.3% in the observation group and 74.1% in the control group. The difference between the two groups was statistically significant. The incidence of adverse reactions in the observation group was 3.7%, while the incidence of adverse reactions in the control group was 18.5%. Conclusion: Mifepristone is effective in clinical treatment of functional uterine bleeding in patients with menopause and has few adverse reactions. It can be widely used clinically.